276 related articles for article (PubMed ID: 16221905)
1. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
Glaiberman CB; Pilgram TK; Brown DB
J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
6. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
7. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
[TBL] [Abstract][Full Text] [Related]
9. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
10. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
12. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
18. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
Chen TM; Huang PT; Lin LF; Tung JN
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
20. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
